Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000049.xml
Download PDF
Clin Colon Rectal Surg 2011; 24(1): 071-080
DOI: 10.1055/s-0031-1272826
© Thieme Medical PublishersDOI: 10.1055/s-0031-1272826
Hidradenitis Suppurativa and Pruritus Ani
Further Information
Publication History
Publication Date:
23 February 2011 (online)
ABSTRACT
Hidradenitis suppurativa (HS) is a chronic debilitating disorder that can affect any areas bearing apocrine glands. Perineal HS is associated with high morbidity compared with other anatomic regions. Early-stage disease may mimic various other forms of cutaneous disorders, but as HS progresses pathognomonic skin changes occur. Clinical stage can guide the therapeutic approach, but the lowest recurrence rate is obtained by removing all involved skin and subcutaneous fat. Pruritus ani is a complex disease with a multitude of etiologies. Its management can be frustrating and disappointing for the patient and doctor alike. The key is to start with simple treatment options focusing on perianal hygiene and avoidance of the most common offending foods and beverages. If these measures fail, topical medications should be attempted before graduating to perianal injections of methylene blue as a last resort.
KEYWORDS
Hidradenitis suppurativa - acne inversa - pruritus ani
REFERENCES
- 1 Singer M, Cintron J R. Hidradentis suppuratuva. Clin Colon Rectal Surg. 2002; 14 233-242
- 2 Anderson Jr M J, Dockerty M B. Perianal hidradenitis suppurativa; a clinical and pathologic study. Dis Colon Rectum. 1958; 1 (1) 23-31
- 3 Shelley W B, Levy E J, Weidman F D. Apocrine sweat retention in man. III. Apocrine retention cysts. AMA Arch Derm. 1955; 72 (2) 171-172
- 4 Yu C C, Cook M G. Hidradenitis suppurativa: a disease of follicular epithelium, rather than apocrine glands. Br J Dermatol. 1990; 122 (6) 763-769
- 5 Anderson B B, Cadogan C A, Gangadharam D. Hidradenitis suppurativa of the perineum, scrotum, and gluteal area: presentation, complications, and treatment. J Natl Med Assoc. 1982; 74 (10) 999-1003
- 6 von der Werth J M, Jemec G B. Morbidity in patients with hidradenitis suppurativa. Br J Dermatol. 2001; 144 (4) 809-813
- 7 Clemmensen O J. Topical treatment of hidradenitis suppurativa with clindamycin. Int J Dermatol. 1983; 22 (5) 325-328
- 8 Mortimer P S, Dawber R P, Gales M A, Moore R A. Mediation of hidradenitis suppurativa by androgens. Br Med J (Clin Res Ed). 1986; 292 (6515) 245-248
- 9 Rose R F, Goodfield M J, Clark S M. Treatment of recalcitrant hidradenitis suppurativa with oral cyclosporin. Clin Exp Dermatol. 2006; 31 (1) 154-155
- 10 Rompel R. [Orientation guides for excision lines and flap design]. J Dtsch Dermatol Ges. 2006; 4 (10) 888-890
- 11 Revuz J E, Canoui-Poitrine F, Wolkenstein P et al.. Prevalence and factors associated with hidradenitis suppurativa: results from two case-control studies. J Am Acad Dermatol. 2008; 59 (4) 596-601
- 12 Jemec G B, Ganslandt C, Ortonne J P et al.. A new scalp formulation of calcipotriene plus betamethasone compared with its active ingredients and the vehicle in the treatment of scalp psoriasis: a randomized, double-blind, controlled trial. J Am Acad Dermatol. 2008; 59 (3) 455-463
- 13 Wiltz O, Schoetz Jr D J, Murray J J, Roberts P L, Coller J A, Veidenheimer M C. Perianal hidradenitis suppurativa. The Lahey Clinic experience. Dis Colon Rectum. 1990; 33 (9) 731-734
- 14 Homma H. On apocrine seat glands in white and Negro men and women. Bull Johns Hopkins Hosp. 1926; 38 365-371
- 15 Paletta C, Jurkiewicz M J. Hidradenitis suppurativa. Clin Plast Surg. 1987; 14 (2) 383-390
- 16 Velpeau A. Un repertoire general des sciences medicales sous la rapport theorique et practique. Dictionnaire de Medecine. 1839; 2 (2) 91-109
- 17 Verneuil A. De l'hidrosadenite phlegmoneuse et des asbces sudoripares. Arch Gen Med. 1864; 2 537-557
- 18 Jemec G B, Heidenheim M, Nielsen N H. Hidradenitis suppurativa—characteristics and consequences. Clin Exp Dermatol. 1996; 21 (6) 419-423
- 19 Bendahan J, Paran H, Kolman S, Neufeld D M, Freund U. The possible role of Chlamydia trachomatis in perineal suppurative hidradenitis. Eur J Surg. 1992; 158 (4) 213-215
- 20 Highet A S, Warren R E, Weekes A J. Bacteriology and antibiotic treatment of perineal suppurative hidradenitis. Arch Dermatol. 1988; 124 (7) 1047-1051
- 21 Harrison B J, Read G F, Hughes L E. Endocrine basis for the clinical presentation of hidradenitis suppurativa. Br J Surg. 1988; 75 (10) 972-975
- 22 Jemec G B. The symptomatology of hidradenitis suppurativa in women. Br J Dermatol. 1988; 119 (3) 345-350
- 23 Morgan W P, Leicester G. The role of depilation and deodorants in hidradenitis suppurativa. Arch Dermatol. 1982; 118 (2) 101-102
- 24 Attanoos R L, Appleton M A, Douglas-Jones A G. The pathogenesis of hidradenitis suppurativa: a closer look at apocrine and apoeccrine glands. Br J Dermatol. 1995; 133 (2) 254-258
- 25 Hana A, Booken D, Henrich C et al.. Functional significance of non-neuronal acetylcholine in skin epithelia. Life Sci. 2007; 80 (24-25) 2214-2220
- 26 Parks R W, Parks T G. Pathogenesis, clinical features and management of hidradenitis suppurativa. Ann R Coll Surg Engl. 1997; 79 (2) 83-89
- 27 Lapins J, Asman B, Gustafsson A, Bergström K, Emtestam L. Neutrophil-related host response in hidradenitis suppurativa: a pilot study in patients with inactive disease. Acta Derm Venereol. 2001; 81 (2) 96-99
- 28 Hunger R E, Surovy A M, Hassan A S, Braathen L R, Yawalkar N. Toll-like receptor 2 is highly expressed in lesions of acne inversa and colocalizes with C-type lectin receptor. Br J Dermatol. 2008; 158 (4) 691-697
- 29 Giamarellos-Bourboulis E J, Pelekanou E, Antonopoulou A et al.. An open-label phase II study of the safety and efficacy of etanercept for the therapy of hidradenitis suppurativa. Br J Dermatol. 2008; 158 (3) 567-572
- 30 Banerjee A K. Surgical treatment of hidradenitis suppurativa. Br J Surg. 1992; 79 (9) 863-866
- 31 Thornton J P, Abcarian H. Surgical treatment of perianal and perineal hidradenitis suppurativa. Dis Colon Rectum. 1978; 21 (8) 573-577
- 32 Culp C E. Chronic hidradenitis suppurativa of the anal canal. A surgical skin disease. Dis Colon Rectum. 1983; 26 (10) 669-676
- 33 Church J M, Fazio V W, Lavery I C, Oakley J R, Milsom J W. The differential diagnosis and comorbidity of hidradenitis suppurativa and perianal Crohn's disease. Int J Colorectal Dis. 1993; 8 (3) 117-119
- 34 Randall K, Roenigk H H. Dermatologic Surgery, Principles and Practice. New York: Marcel Dekker; 1989
- 35 Sartorius K, Lapins J, Emtestam L, Jemec G B. Suggestions for uniform outcome variables when reporting treatment effects in hidradenitis suppurativa. Br J Dermatol. 2003; 149 (1) 211-213
- 36 Alikhan A, Lynch P J, Eisen D B. Hidradenitis suppurativa: a comprehensive review. J Am Acad Dermatol. 2009; 60 (4) 539-561 quiz 562-563
- 37 Pérez-Diaz D, Calvo-Serrano M, Mártinez-Hijosa E et al.. Squamous cell carcinoma complicating perianal hidradenitis suppurativa. Int J Colorectal Dis. 1995; 10 (4) 225-228
- 38 Anstey A V, Wilkinson J D, Lord P. Squamous cell carcinoma complicating hidradenitis suppurativa. Br J Dermatol. 1990; 123 (4) 527-531
- 39 Radcliffe K W. Hidradenitis suppurativa. Genitourin Med. 1991; 67 (1) 58
- 40 Williams S T, Busby R C, DeMuth R J, Nelson H. Perineal hidradenitis suppurativa: presentation of two unusual complications and a review. Ann Plast Surg. 1991; 26 (5) 456-462
- 41 Konety B R, Cooper T, Flood H D, Futrell J W. Scrotal elephantiasis associated with hidradenitis suppurativa. Plast Reconstr Surg. 1996; 97 (6) 1243-1245
- 42 Krbec A C. Current understanding and management of hidradenitis suppurativa. J Am Acad Nurse Pract. 2007; 19 (5) 228-234
- 43 Mendonça H, Rebelo C, Fernandes A, Lino A, Garcia e Silva L. Squamous cell carcinoma arising in hidradenitis suppurativa. J Dermatol Surg Oncol. 1991; 17 (10) 830-832
- 44 Brown C F, Gallup D G, Brown V M. Hidradenitis suppurativa of the anogenital region: response to isotretinoin. Am J Obstet Gynecol. 1988; 158 (1) 12-15
- 45 Boer J, van Gemert M J. Long-term results of isotretinoin in the treatment of 68 patients with hidradenitis suppurativa. J Am Acad Dermatol. 1999; 40 (1) 73-76
- 46 Joseph M A, Jayaseelan E, Ganapathi B, Stephen J. Hidradenitis suppurativa treated with finasteride. J Dermatolog Treat. 2005; 16 (2) 75-78
- 47 Buckley D A, Rogers S. Cyclosporin-responsive hidradenitis suppurativa. J R Soc Med. 1995; 88 (5) 289P-290P
- 48 Bolanowski A, Mannon R B, Holland S M et al.. Successful renal transplantation in patients with chronic granulomatous disease. Am J Transplant. 2006; 6 (3) 636-639
- 49 Sullivan T P, Welsh E, Kerdel F A, Burdick A E, Kirsner R S. Infliximab for hidradenitis suppurativa. Br J Dermatol. 2003; 149 (5) 1046-1049
- 50 Cusack C, Buckley C. Etanercept: effective in the management of hidradenitis suppurativa. Br J Dermatol. 2006; 154 (4) 726-729
- 51 Zeligman I. Temporary x-ray epilation therapy of chronic axillary hidradenitis suppurativa. Arch Dermatol. 1965; 92 (6) 690-694
- 52 Lapins J, Sartorius K, Emtestam L. Scanner-assisted carbon dioxide laser surgery: a retrospective follow-up study of patients with hidradenitis suppurativa. J Am Acad Dermatol. 2002; 47 (2) 280-285
- 53 Bong J L, Shalders K, Saihan E. Treatment of persistent painful nodules of hidradenitis suppurativa with cryotherapy. Clin Exp Dermatol. 2003; 28 (3) 241-244
- 54 Ritz J P, Runkel N, Haier J, Buhr H J. Extent of surgery and recurrence rate of hidradenitis suppurativa. Int J Colorectal Dis. 1998; 13 (4) 164-168
- 55 Brown S C, Kazzazi N, Lord P H. Surgical treatment of perineal hidradenitis suppurativa with special reference to recognition of the perianal form. Br J Surg. 1986; 73 (12) 978-980
- 56 Watson J D. Hidradenitis suppurativa—a clinical review. Br J Plast Surg. 1985; 38 (4) 567-569
- 57 Harrison B J, Kumar S, Read G F, Edwards C A, Scanlon M F, Hughes L E. Hidradenitis suppurativa: evidence for an endocrine abnormality. Br J Surg. 1985; 72 (12) 1002-1004
- 58 Kagan R J, Yakuboff K P, Warner P, Warden G D. Surgical treatment of hidradenitis suppurativa: a 10-year experience. Surgery. 2005; 138 (4) 734-740 discussion 740-741
- 59 Ramasastry S S, Conklin W T, Granick M S, Futrell J W. Surgical management of massive perianal hidradenitis suppurativa. Ann Plast Surg. 1985; 15 (3) 218-223
- 60 Solanki N S, Roshan A, Malata C M. Pedicled gracilis myocutaneous flap for treatment of recalcitrant hidradenitis suppurativa of the groin and perineum. J Wound Care. 2009; 18 (3) 111-112
- 61 Rompel R, Petres J. Long-term results of wide surgical excision in 106 patients with hidradenitis suppurativa. Dermatol Surg. 2000; 26 (7) 638-643
- 62 Markell K W, Billingham R P. Pruritus ani: etiology and management. Surg Clin North Am. 2010; 90 (1) 125-135
- 63 Siddiqi S, Vijay V, Ward M, Mahendran R, Warren S. Pruritus ani. Ann R Coll Surg Engl. 2008; 90 (6) 457-463
- 64 Stermer E, Sukhotnic I, Shaoul R. Pruritus ani: an approach to an itching condition. J Pediatr Gastroenterol Nutr. 2009; 48 (5) 513-516
- 64a Vincent C. Anorectal pain and irritation: anal fissure, levator syndrome, proctalgia fugax and pruritus ani. Prim Care. 1999; 26 (1) 53-68
- 65 Lacy B E, Weiser K. Common anorectal disorders: diagnosis and treatment. Curr Gastroenterol Rep. 2009; 11 (5) 413-419
- 66 Kränke B, Trummer M, Brabek E, Komericki P, Turek T D, Aberer W. Etiologic and causative factors in perianal dermatitis: results of a prospective study in 126 patients. Wien Klin Wochenschr. 2006; 118 (3-4) 90-94
- 67 Jongen J, Eberstein A, Peleikis H G, Kahlke V, Herbst R A. Perianal streptococcal dermatitis: an important differential diagnosis in pediatric patients. Dis Colon Rectum. 2008; 51 (5) 584-587
- 68 Singh S P, Panda C, Rout N, Mishra A P. Anal albendazole application for pruritus ani in threadworm infestation. J Trop Pediatr. 2005; 51 (6) 386
- 69 Caplan R M. The irritant role of feces in the genesis of perianal itch. Gastroenterology. 1966; 50 (1) 19-23
- 70 Smith L E, Henrichs D, McCullah R D. Prospective studies on the etiology and treatment of pruritus ani. Dis Colon Rectum. 1982; 25 (4) 358-363
- 71 McKenna K E. Allergic contact dermatitis from glyceryl trinitrate ointment. Contact Dermat. 2000; 42 (4) 246
- 72 Hejna M, Valencak J, Raderer M. Anal pruritus after cancer chemotherapy with gemcitabine. N Engl J Med. 1999; 340 (8) 655-656
- 73 Pfenninger J L, Zainea G G. Common anorectal conditions. Part I. Symptoms and complaints. Am Fam Physician. 2001; 63 (12) 2391-2398
- 74 Kuehn H G, Gebbensleben O, Hilger Y, Rohde H. Relationship between anal symptoms and anal findings. Int J Med Sci. 2009; 6 (2) 77-84
- 75 Zuccati G, Lotti T, Mastrolorenzo A, Rapaccini A, Tiradritti L. Pruritus ani. Dermatol Ther. 2005; 18 (4) 355-362
- 76 Weichert G E. An approach to the treatment of anogenital pruritus. Dermatol Ther. 2004; 17 (1) 129-133
- 77 Dasan S, Neill S M, Donaldson D R, Scott H J. Treatment of persistent pruritus ani in a combined colorectal and dermatological clinic. Br J Surg. 1999; 86 (10) 1337-1340
- 78 Handa Y, Watanabe O, Adachi A, Yamanaka N. Squamous cell carcinoma of the anal margin with pruritus ani of long duration. Dermatol Surg. 2003; 29 (1) 108-110
- 79 Mazier W P. Hemorrhoids, fissures, and pruritus ani. Surg Clin North Am. 1994; 74 (6) 1277-1292
- 80 Gopal D V. Diseases of the rectum and anus: a clinical approach to common disorders. Clin Cornerstone. 2002; 4 (4) 34-48
- 81 Al-Ghnaniem R, Short K, Pullen A, Fuller L C, Rennie J A, Leather A J. 1% hydrocortisone ointment is an effective treatment of pruritus ani: a pilot randomized controlled crossover trial. Int J Colorectal Dis. 2007; 22 (12) 1463-1467
- 82 Oztaş M O, Oztaş P, Onder M. Idiopathic perianal pruritus: washing compared with topical corticosteroids. Postgrad Med J. 2004; 80 (943) 295-297
- 83 Lysy J, Sistiery-Ittah M, Israelit Y et al.. Topical capsaicin—a novel and effective treatment for idiopathic intractable pruritus ani: a randomised, placebo controlled, crossover study. Gut. 2003; 52 (9) 1323-1326
- 84 Mentes B B, Akin M, Leventoglu S, Gultekin F A, Oguz M. Intradermal methylene blue injection for the treatment of intractable idiopathic pruritus ani: results of 30 cases. Tech Coloproctol. 2004; 8 (1) 11-14
- 85 Sutherland A D, Faragher I G, Frizelle F A. Intradermal injection of methylene blue for the treatment of refractory pruritus ani. Colorectal Dis. 2009; 11 (3) 282-287
- 86 Botterill I D, Sagar P M. Intra-dermal methylene blue, hydrocortisone and lignocaine for chronic, intractable pruritus ani. Colorectal Dis. 2002; 4 (2) 144-146
- 87 Rucklidge J J, Saunders D. Hypnosis in a case of long-standing idiopathic itch. Psychosom Med. 1999; 61 (3) 355-358
Martin A LuchtefeldM.D.
Division of Colon and Rectal Surgery, Spectrum Health
4100 Lake Dr. SE, Ste 205, Grand Rapids, MI 49546
Email: Mluchtefeld@gmail.com